Renin-Angiotensin System Inhibitor Usage and Age-Related Macular Degeneration among Hypertensive Patients: Results from the National Health and Nutrition Examination Survey, 2005–2008

Table 2

Age- and multivariate-adjusted ORs for any AMD among the study population.

	Age-adjusted		Multivariate-adjusted^‡
	OR (95% CI)		OR^† (95% CI)
RASI usage	1.17 (0.88–1.57)	0.27	1.32 (0.83–2.08)	0.22
RASI category^†
ACEI	1.31 (0.98–1.74)	0.06	1.37 (0.94–2.00)	0.09
ARB	0.93 (0.59–1.48)	0.76	1.22 (0.53–2.79)	0.62

^‡Adjusted for age, stroke history, cataract surgery history, heart disease, and HDL. ^†Except participants taking both ACEI and ARB. Reference group: RASI nonusers.. OR: odds ratio; AMD: age-related macular degeneration; CI: confidence interval; RASI: renin-angiotensin system inhibitor; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; HDL: high-density lipoprotein.